Sugie H - Search Results

1

Study of HOXD genes in autism particularly regarding the ratio of second to fourth digit length.

Sugie Y, Sugie H, Fukuda T, Osawa J. Sugie Y, et al. Among authors: sugie h. Brain Dev. 2010 May;32(5):356-61. doi: 10.1016/j.braindev.2009.05.005. Epub 2009 Jun 18. Brain Dev. 2010. PMID: 19540081

2

[Serotonin 2A receptor gene polymorphism and clinical efficacy of fluvoxamine in children with autistic disorder].

Sugie Y, Sugie H, Fukuda T, Ito M, Ohzeki T. Sugie Y, et al. Among authors: sugie h. No To Hattatsu. 2003 Jan;35(1):23-8. No To Hattatsu. 2003. PMID: 12607287 Clinical Trial. Japanese.

3

[Studies on the adverse effects of fluvoxamine treatment in children with autistic disorder: correlation with genetic polymorphism in serotonin related genes].

Sugie Y, Sugie H, Fukuda T, Ito M, Ohzeki T. Sugie Y, et al. Among authors: sugie h. No To Hattatsu. 2003 May;35(3):233-7. No To Hattatsu. 2003. PMID: 12755054 Japanese.

4

[Clinical evaluation of treatment with fluvoxamine, a selective serotonin reuptake inhibitor in children with autistic disorder].

Fukuda T, Sugie H, Ito M, Sugie Y. Fukuda T, et al. Among authors: sugie h, sugie y. No To Hattatsu. 2001 Jul;33(4):314-8. No To Hattatsu. 2001. PMID: 11494573 Japanese.

5

[Evaluation of the 2nd to 4th digit ratio in the patients with autism].

Osawa J, Sugie H, Fukuda T, Ito M, Sugie Y, Ohzeki T. Osawa J, et al. Among authors: sugie h, sugie y. No To Hattatsu. 2005 Sep;37(5):424-5. No To Hattatsu. 2005. PMID: 16164250 Japanese. No abstract available.

6

Clinical efficacy of fluvoxamine and functional polymorphism in a serotonin transporter gene on childhood autism.

Sugie Y, Sugie H, Fukuda T, Ito M, Sasada Y, Nakabayashi M, Fukashiro K, Ohzeki T. Sugie Y, et al. Among authors: sugie h. J Autism Dev Disord. 2005 Jun;35(3):377-85. doi: 10.1007/s10803-005-3305-2. J Autism Dev Disord. 2005. PMID: 16119478 Clinical Trial.

7

Neonatal factors in infants with Autistic Disorder and typically developing infants.

Sugie Y, Sugie H, Fukuda T, Ito M. Sugie Y, et al. Among authors: sugie h. Autism. 2005 Dec;9(5):487-94. doi: 10.1177/1362361305057877. Autism. 2005. PMID: 16287701

8

Another promising treatment option for neuroblastoma-associated opsoclonus-myoclonus syndrome by oral high-dose dexamethasone pulse: lymphocyte markers as disease activity.

Oguma M, Morimoto A, Takada A, Kashii Y, Fukuda T, Mori M, Yamagata T, Sugie H, Momoi MY. Oguma M, et al. Among authors: sugie h. Brain Dev. 2012 Mar;34(3):251-4. doi: 10.1016/j.braindev.2011.04.005. Epub 2011 Apr 29. Brain Dev. 2012. PMID: 21531096

9

A case of ADEM with atypical MRI findings of a centrally-located long spinal cord lesion.

Monden Y, Yamagata T, Kuroiwa Y, Takahashi T, Mori M, Fukuda T, Sugie H, Momoi MY. Monden Y, et al. Among authors: sugie h. Brain Dev. 2012 May;34(5):380-3. doi: 10.1016/j.braindev.2011.06.010. Epub 2011 Jul 23. Brain Dev. 2012. PMID: 21783334

10

[Enzyme Replacement Therapy for Pompe Disease: The Long-Term Efficacy and Limitation].

Fukuda T, Sugie H. Fukuda T, et al. Among authors: sugie h. Brain Nerve. 2015 Sep;67(9):1091-8. doi: 10.11477/mf.1416200265. Brain Nerve. 2015. PMID: 26329149 Review. Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

197 results

Search Page

Filters